Teva, Fedex Shares Look Fantastic Says MainStay Fund Manager
Shares of Teva Pharmaceuticals remain relatively inexpensive despite the stock's sharp move higher this year, said Andrew Ver Planck, portfolio manager for the MainStay International Opportunities Fund.
Shares of Teva Pharmaceuticals remain relatively inexpensive despite the stock's sharp move higher this year, said Andrew Ver Planck, portfolio manager for the MainStay International Opportunities Fund. Ver Planck added that Teva is increasing profit margins and posted strong third quarter results. He is also bullish on shares of FedEx, which he owns in the Mainstay US Equity Opportunities Fund, due to lower oil prices and forecasts for a strong holiday retail season. Finally, Ver Planck is negative on Arch Coal, saying that coal is in a secular bear market as the government is pushing utilities to switch to natural gas from coal.









